Skip to content
DataLookout
Menu

HARPNCT06006143

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2

StatusTerminated
PhasePhase 2
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 11 versions: 11 with changes below. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial terminated Sponsor's reason: recruitment challenges Show 4 more changesShow less
    • Eligibility criteria expanded, about 18 words
    • Final enrollment: 3 participants (planned 30)
    • Primary and study completion dates changed from estimate of Aug 31, 2026 to Aug 5, 2026
    • Secondary endpoints: details revised at 1 of 2 entries
  2. Minor Trial status changed: Recruiting → Active, Not Recruiting
    • Site details revised
    v10
  3. Notable Primary and study completion dates: Dec 31, 2025 to Aug 31, 2026v9
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 2025 to Jun 16, 2025
    • Site details revised
    v8
  5. Notable Start date: Apr 2025 to Jun 2025v7
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Eligibility criteria shortened, about 1 word
    • Study description expanded, about 5 words
    v6
  2. Notable Start date: Mar 1, 2025 to Apr 2025v5
  3. Notable Start date: Jan 1, 2025 to Mar 1, 2025v4
  4. Notable Phase: Not applicable to Phase 2
    • Study sites: 0 to 1
    v3
  5. Notable Start date: Sep 1, 2024 to Jan 1, 2025
    • Primary and study completion dates: Aug 31, 2025 to Dec 31, 2025
    v2
  1. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Proportion of participants who complete enrollment and duration of sessions
Timeframe: 12 weeks
Number of sessions completed
Timeframe: 12 weeks
Adherence to Medication
Timeframe: 12 weeks
Safety of study assessed by adverse events reporting
Timeframe: 12 weeks

Secondary (2)

Efficacy of study - change in self-reported alcohol use
Efficacy of study - change in PEth (phosphatidylethanol) results

Arms and interventions

VareniclineExperimental

Participants will receive a prescription for generic varenicline

Drugs: Varenicline

Sites

1 site in 1 country

  • Atlanta VA Medical CenterDecatur, Georgia, United States